Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

innovation   crawled date : 2021 - 06 - 22    save search

The Platforms for Advanced Wireless Research (PAWR) Program Announces Fourth Wireless Research Platform in Central Iowa to Drive Innovation in Rural Broadband Connectivity
Published: 2021-06-22 (Crawled : 19:00) - prnewswire.com
ERIC | News | $5.1 0.79% 0.78% 19M twitter stocktwits trandingview |
Electronic Technology
| | O: -2.26% H: 0.4% C: -0.96%

research platform
Westwater Bringing Innovative Graphite-Processing Plant, Jobs to Alabama
Published: 2021-06-22 (Crawled : 17:00) - westwaterresources.net
WWR 4 | $0.4499 0.04% -0.87% 67K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -1.12% H: 28.96% C: 19.23%


Government Policies Encouraging Use of Electric Vehicles to Reduce Environmental Pollution to Boost Electric Vehicle Charging Station Market, Innovations in Automotive Technology to Intensify Competition - TMR
Published: 2021-06-22 (Crawled : 16:00) - prnewswire.com
GE | News | $148.06 -3.19% 0.0% 9.5M twitter stocktwits trandingview |
Electronic Technology
| | O: -0.53% H: 0.57% C: -0.69%

electric vehicle technology charging vehicles charging station
TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment of Cancer and Inflammatory Diseases
Published: 2021-06-22 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.2% C: -0.05%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.02% H: 0.44% C: -0.53%

disease treatment cancer
Tarsus Pharmaceuticals, Inc. to Participate in the Raymond James 2021 Human Health Innovation Conference
Published: 2021-06-22 (Crawled : 11:00) - globenewswire.com
TARS | $32.405 -1.36% -1.37% 630K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -1.72%

conference health
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
Published: 2021-06-22 (Crawled : 01:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.02% H: 0.44% C: -0.53%
INCY | $52.3 -0.98% -0.99% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.99% C: -0.07%

treatment ev approval
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.